Bell Investment Advisors, Inc Biotechnology

Bell Investment Advisors, Inc

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
CTMX Cytom X Therapeutics, Inc.	$38.9M	$0 0.0% of portfolio	388	Q4 2024 New
FATE Fate Therapeutics Inc	$82.5M	$0 0.0% of portfolio	260	Q4 2023 New
GMAB Genmab A/S	$12.9B	$0 0.0% of portfolio	36	Q3 2024 Reduced 35.71%
HRMY Harmony Biosciences Holdings, Inc.	$1.96B	$0 0.0% of portfolio	23	Q4 2024 New
IDYA Ideaya Biosciences, Inc.	$820M	$0 0.0% of portfolio	32	Q4 2024 Reduced 37.25%
IMTX Immatics N.V.	$353M	$0 0.0% of portfolio	64	Q4 2024 New
IMCR Immunocore Holdings PLC	$1.3B	$0 0.0% of portfolio	14	Q3 2024 Reduced 48.15%
NTLA Intellia Therapeutics, Inc.	$613M	$0 0.0% of portfolio	13	Q3 2024 Reduced 75.93%
IOVA Iovance Biotherapeutics, Inc.	$562M	$0 0.0% of portfolio	107	Q3 2024 Added 148.84%
MDGL Madrigal Pharmaceuticals, Inc.	$5.61B	$0 0.0% of portfolio	3	Q3 2023 New
NUVL Nuvalent, Inc.	$3.14B	$0 0.0% of portfolio	7	Q4 2024 Reduced 58.82%
PTGX Protagonist Therapeutics, Inc	$2.4B	$0 0.0% of portfolio	17	Q1 2024 New
SAGE Sage Therapeutics, Inc.	$492M	$0 0.0% of portfolio	107	Q4 2024 Added 494.44%
MCRB Seres Therapeutics, Inc.	$89.3M	$0 0.0% of portfolio	611	Q4 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$2.65B	$0 0.0% of portfolio	11	Q3 2023 Reduced 77.55%
VRNA Verona Pharma PLC	$3.82B	$0 0.0% of portfolio	13	Q4 2024 Reduced 40.91%
VKTX Viking Therapeutics, Inc.	$1.97B	$0 0.0% of portfolio	10	Q4 2024 Reduced 54.55%
VIR Vir Biotechnology, Inc.	$889M	$0 0.0% of portfolio	27	Q3 2023 Reduced 64.0%
XNCR Xencor Inc	$670M	$0 0.0% of portfolio	19	Q2 2023 Reduced 47.22%

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.